Literature DB >> 23852814

Chemotherapy altered brain functional connectivity in women with breast cancer: a pilot study.

Julie A Dumas1, Jenna Makarewicz, Geoffrey J Schaubhut, Robert Devins, Kimberly Albert, Kim Dittus, Paul A Newhouse.   

Abstract

Adjuvant chemotherapy is associated with improvements in long-term cancer survival. However, reports of cognitive impairment following treatment emphasize the importance of understanding the long-term effects of chemotherapy on brain functioning. Cognitive deficits found in chemotherapy patients suggest a change in brain functioning that affects specific cognitive domains such as attentional processing and executive functioning. This study examined the processes potentially underlying these changes in cognition by examining brain functional connectivity pre- and post-chemotherapy in women with breast cancer. Functional connectivity examines the temporal correlation between spatially remote brain regions in an effort to understand how brain networks support specific cognitive functions. Nine women diagnosed with breast cancer completed a functional magnetic resonance imaging (fMRI) session before chemotherapy, 1 month after, and 1 year after the completion of chemotherapy. Seed-based functional connectivity analyses were completed using seeds in the intraparietal sulcus (IPS) to examine connectivity in the dorsal anterior attention network and in the posterior cingulate cortex (PCC) to examine connectivity in the default mode network. Results showed decreased functional connectivity 1 month after chemotherapy that partially returned to baseline at 1 year in the dorsal attention network. Decreased connectivity was seen in the default mode network at 1 month and 1 year following chemotherapy. In addition, increased subjective memory complaints were noted at 1 month and 1 year post-chemotherapy. These findings suggest a detrimental effect of chemotherapy on brain functional connectivity that is potentially related to subjective cognitive assessment.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23852814      PMCID: PMC3852152          DOI: 10.1007/s11682-013-9244-1

Source DB:  PubMed          Journal:  Brain Imaging Behav        ISSN: 1931-7557            Impact factor:   3.978


  41 in total

1.  Alterations in brain activation during working memory processing associated with breast cancer and treatment: a prospective functional magnetic resonance imaging study.

Authors:  Brenna C McDonald; Susan K Conroy; Tim A Ahles; John D West; Andrew J Saykin
Journal:  J Clin Oncol       Date:  2012-06-04       Impact factor: 44.544

2.  A method for using blocked and event-related fMRI data to study "resting state" functional connectivity.

Authors:  Damien A Fair; Bradley L Schlaggar; Alexander L Cohen; Francis M Miezin; Nico U F Dosenbach; Kristin K Wenger; Michael D Fox; Abraham Z Snyder; Marcus E Raichle; Steven E Petersen
Journal:  Neuroimage       Date:  2007-01-18       Impact factor: 6.556

3.  Neuropsychological performance in survivors of breast cancer more than 20 years after adjuvant chemotherapy.

Authors:  Vincent Koppelmans; Monique M B Breteler; Willem Boogerd; Caroline Seynaeve; Chad Gundy; Sanne B Schagen
Journal:  J Clin Oncol       Date:  2012-02-27       Impact factor: 44.544

4.  Brief Cognitive Rating Scale (BCRS).

Authors:  B Reisberg; S H Ferris
Journal:  Psychopharmacol Bull       Date:  1988

5.  The effects of adjuvant chemotherapy on cognition in women with breast cancer--preliminary results of an observational longitudinal study.

Authors:  V Shilling; V Jenkins; R Morris; G Deutsch; D Bloomfield
Journal:  Breast       Date:  2005-04       Impact factor: 4.380

Review 6.  Chemotherapy and cognition: effects, potential mechanisms, and management.

Authors:  Anne E Kayl; Jeffrey S Wefel; Christina A Meyers
Journal:  Am J Ther       Date:  2006 Jul-Aug       Impact factor: 2.688

7.  Cerebral hyporesponsiveness and cognitive impairment 10 years after chemotherapy for breast cancer.

Authors:  Michiel B de Ruiter; Liesbeth Reneman; Willem Boogerd; Dick J Veltman; Frits S A M van Dam; Aart J Nederveen; Epie Boven; Sanne B Schagen
Journal:  Hum Brain Mapp       Date:  2010-07-28       Impact factor: 5.038

8.  Intrinsic architecture underlying the relations among the default, dorsal attention, and frontoparietal control networks of the human brain.

Authors:  R Nathan Spreng; Jorge Sepulcre; Gary R Turner; W Dale Stevens; Daniel L Schacter
Journal:  J Cogn Neurosci       Date:  2012-08-20       Impact factor: 3.225

9.  Cognitive effects of chemotherapy in post-menopausal breast cancer patients 1 year after treatment.

Authors:  Barbara Collins; Joyce Mackenzie; Angela Stewart; Catherine Bielajew; Shailendra Verma
Journal:  Psychooncology       Date:  2009-02       Impact factor: 3.894

10.  Longitudinal assessment of cognitive changes associated with adjuvant treatment for breast cancer: impact of age and cognitive reserve.

Authors:  Tim A Ahles; Andrew J Saykin; Brenna C McDonald; Yuelin Li; Charlotte T Furstenberg; Brett S Hanscom; Tamsin J Mulrooney; Gary N Schwartz; Peter A Kaufman
Journal:  J Clin Oncol       Date:  2010-09-13       Impact factor: 44.544

View more
  32 in total

1.  The usefulness of sLORETA in evaluating the effect of high-dose ARA-C on brain connectivity in patients with acute myeloid leukemia: an exploratory study.

Authors:  A Zarabla; S Ungania; A Cacciatore; A Maialetti; G Petreri; A Mengarelli; A Spadea; F Marchesi; D Renzi; Svitlana Gumenyuk; L Strigari; Marta Maschio
Journal:  Funct Neurol       Date:  2017 Oct/Dec

Review 2.  Default mode network as a potential biomarker of chemotherapy-related brain injury.

Authors:  Shelli R Kesler
Journal:  Neurobiol Aging       Date:  2014-05-15       Impact factor: 4.673

Review 3.  Prevalence, mechanisms, and management of cancer-related cognitive impairment.

Authors:  Michelle C Janelsins; Shelli R Kesler; Tim A Ahles; Gary R Morrow
Journal:  Int Rev Psychiatry       Date:  2014-02

4.  Neuroimaging biomarkers and cognitive function in non-CNS cancer and its treatment: current status and recommendations for future research.

Authors:  Andrew J Saykin; Michiel B de Ruiter; Brenna C McDonald; Sabine Deprez; Daniel H S Silverman
Journal:  Brain Imaging Behav       Date:  2013-12       Impact factor: 3.978

5.  Systematic review of self-reported cognitive function in cancer patients following chemotherapy treatment.

Authors:  Victoria J Bray; Haryana M Dhillon; Janette L Vardy
Journal:  J Cancer Surviv       Date:  2018-05-04       Impact factor: 4.442

Review 6.  Clinical characteristics, pathophysiology, and management of noncentral nervous system cancer-related cognitive impairment in adults.

Authors:  Jeffrey S Wefel; Shelli R Kesler; Kyle R Noll; Sanne B Schagen
Journal:  CA Cancer J Clin       Date:  2014-12-05       Impact factor: 508.702

Review 7.  Chemotherapy-related cognitive impairment in older patients with cancer.

Authors:  Kah Poh Loh; Michelle C Janelsins; Supriya G Mohile; Holly M Holmes; Tina Hsu; Sharon K Inouye; Meghan S Karuturi; Gretchen G Kimmick; Stuart M Lichtman; Allison Magnuson; Mary I Whitehead; Melisa L Wong; Tim A Ahles
Journal:  J Geriatr Oncol       Date:  2016-07-05       Impact factor: 3.599

8.  Associations Between Physical Fitness Indices and Working Memory in Breast Cancer Survivors and Age-Matched Controls.

Authors:  Michael J Mackenzie; Krystle E Zuniga; Lauren B Raine; Elizabeth A Awick; Charles H Hillman; Arthur F Kramer; Edward McAuley
Journal:  J Womens Health (Larchmt)       Date:  2015-09-29       Impact factor: 2.681

9.  Neurotoxic Effects of Anthracycline- vs Nonanthracycline-Based Chemotherapy on Cognition in Breast Cancer Survivors.

Authors:  Shelli R Kesler; Douglas W Blayney
Journal:  JAMA Oncol       Date:  2016-02       Impact factor: 31.777

10.  Imaging Brain Networks After Cancer and Chemotherapy: Advances Toward Etiology and Unanswered Questions.

Authors:  Kelly N H Nudelman; Brenna C McDonald; Andrew J Saykin
Journal:  JAMA Oncol       Date:  2016-02       Impact factor: 31.777

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.